Alliance Pharma PLC Preliminary Results -5-
March 25 2015 - 2:01AM
UK Regulatory
The adjusted basic EPS is intended to demonstrate recurring
elements of the results of the Group before exceptional items. A
reconciliation of the earnings used in the different measures is
given below:
Year ended Year ended
31 December 31 December
2014 2013
GBP 000s GBP 000s
Earnings for basic EPS 8,385 9,584
Exceptional items 622 -
Tax effect of exceptional items (124) -
For adjusted EPS 8,883 9,584
---------------------------------- ------------ ------------
Earnings for basic EPS 8,385 9,584
----------------------------------- ----- -----
Interest saving on conversion of
CULS - 204
Tax effect of interest saving on
conversion of CULS - (47)
----------------------------------- ----- -----
Earnings for diluted EPS 8,385 9,741
----------------------------------- ----- -----
Earnings for adjusted EPS 8,883 9,584
------------------------------------ ----- -----
Interest saving on conversion of
CULS - 204
Tax effect of interest saving on
conversion of CULS - (47)
------------------------------------ ----- -----
Earnings for diluted adjusted EPS 8,883 9,741
------------------------------------ ----- -----
The resulting EPS measures are:
Year ended Year ended
31 December 31 December
2014 2013
Pence Pence
--------------------- ------------ ------------
Basic EPS 3.17 3.82
----------------------- ------------ ------------
Diluted EPS 3.16 3.68
----------------------- ------------ ------------
Adjusted basic EPS 3.36 3.82
----------------------- ------------ ------------
Adjusted diluted EPS 3.34 3.68
----------------------- ------------ ------------
6. Intangible assets
Technical
know-how,
trademarks
Goodwill Purchased and distribution Development
on consolidation Goodwill rights costs Total
The Group GBP 000s GBP 000s GBP 000s GBP 000s GBP 000s
---------------------------- ----------------- --------- ----------------- ----------- --------
Cost
At 1 January 2014 1,144 2,449 85,687 373 89,653
Additions - - 2,817 58 2,875
At 31 December 2014 1,144 2,449 88,504 431 92,528
---------------------------- ----------------- --------- ----------------- ----------- --------
Amortisation and impairment
At 1 January 2014 - - 2,543 - 2,543
Amortisation charge
for the year - - 488 - 488
Impairment for the
year - - 622 - 622
---------------------------- ----------------- --------- ----------------- ----------- --------
At 31 December 2014 - - 3,653 - 3,653
---------------------------- ----------------- --------- ----------------- ----------- --------
Net book amount
At 31 December 2014 1,144 2,449 84,851 431 88,875
---------------------------- ----------------- --------- ----------------- ----------- --------
At 1 January 2014 1,144 2,449 83,145 373 87,111
---------------------------- ----------------- --------- ----------------- ----------- --------
Technical
know-how,
trademarks
and distribution
Goodwill Purchased rights Development Total
on consolidation Goodwill Restated costs Restated
The Group GBP 000s GBP 000s GBP 000s GBP 000s GBP 000s
---------------------------- ----------------- --------- ----------------- ----------- ---------
Cost
At 1 January 2013 1,144 2,449 76,157 310 80,060
Additions - - 9,534 63 9,597
Disposals - - (4) - (4)
---------------------------- ----------------- --------- ----------------- ----------- ---------
At 31 December 2013 1,144 2,449 85,687 373 89,653
---------------------------- ----------------- --------- ----------------- ----------- ---------
Amortisation and impairment
At 1 January 2013 - - 2,120 - 2,120
Amortisation for the
year - - 422 - 422
---------------------------- ----------------- --------- ----------------- ----------- ---------
At 31 December 2013 - - 2,542 - 2,542
---------------------------- ----------------- --------- ----------------- ----------- ---------
Net book amount
At 31 December 2013 1,144 2,449 83,145 373 87,111
---------------------------- ----------------- --------- ----------------- ----------- ---------
At 1 January 2013 1,144 2,449 74,037 310 77,940
---------------------------- ----------------- --------- ----------------- ----------- ---------
7. Trade and other receivables
31 December 31 December
2014 2013
GBP 000s GBP 000s
------------------------- ------------ ------------
Trade receivables 6,645 9,131
Other receivables 669 536
Prepayments and accrued
income 453 804
Amounts owed by joint
venture 555 170
-------------------------- ------------ ------------
8,322 10,641
------------------------- ------------ ------------
8. Trade and other payables - current
31 December 31 December
2014 2013
GBP 000s GBP 000s
------------------------ ------------ ------------
Trade payables 1,693 1,118
Other taxes and social
security costs 969 1,069
Accruals and deferred
income 4,065 6,028
Other payables 193 316
------------------------- ------------ ------------
6,920 8,531
------------------------ ------------ ------------
9. Cash generated from operations
Year ended Year ended
31 December 31 December
2014 2013
GBP 000s GBP 000s
----------------------------- ------------ ------------
Result for the period before
tax 10,157 12,009
Interest paid 1,098 1,281
Interest income (48) (50)
Other finance costs (28) 72
Depreciation of property,
plant and equipment 307 266
Amortisation/Impairment of
intangibles 1,110 422
Change in inventories (446) (75)
Change in investments (312) 48
Change in trade and other
receivables 2,823 (1,134)
Change in trade and other
payables (1,781) (1,574)
Share options charges 571 632
-------------------------------- ------------ ------------
Cash flows from operating
activities 13,451 11,897
-------------------------------- ------------ ------------
10. Cash and cash equivalents
31 December 31 December
2014 2013
GBP 000s GBP 000s
----------------- ----------- -----------
Cash at bank and
in hand 1,434 687
Working capital
facility (414) (2,125)
1,020 (1,438)
----------------- ----------- -----------
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2024 to May 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From May 2023 to May 2024